DekaBank Deutsche Girozentrale
RIGL icon

DekaBank Deutsche Girozentrale’s Rigel Pharmaceuticals RIGL Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,960
Closed -$178K – 1470
2021
Q3 		$178K Hold
4,960
– – ﹤0.01% 1227
2021
Q2 		$219K Hold
4,960
– – ﹤0.01% 1201
2021
Q1 		$167K Hold
4,960
– – ﹤0.01% 1213
2020
Q4 		$172K Hold
4,960
– – ﹤0.01% 1202
2020
Q3 		$111K Buy
+4,960
New +$122K ﹤0.01% 1117
2019
Q4 		– Sell
-5,100
Closed -$93K – 1210
2019
Q3 		$93K Sell
5,100
-5,100
-50% -$105K ﹤0.01% 918
2019
Q2 		$250K Buy
10,200
+3,950
+63% +$89.2K ﹤0.01% 995
2019
Q1 		$207K Buy
6,250
+1,150
+23% +$26.3K ﹤0.01% 1037
2018
Q4 		$114K Sell
5,100
-1,150
-18% -$32.5K ﹤0.01% 1048
2018
Q3 		$207K Hold
6,250
– – ﹤0.01% 1059
2018
Q2 		$178K Hold
6,250
– – ﹤0.01% 1060
2018
Q1 		$232K Buy
+6,250
New +$250K ﹤0.01% 974
2016
Q2 		– Sell
-4,600
Closed -$94K – 1035
2016
Q1 		$94K Buy
+4,600
New +$113K ﹤0.01% 971
2015
Q1 		– Sell
-4,690
Closed -$106K – 1165
2014
Q4 		$106K Sell
4,690
-450
-9% -$9.1K ﹤0.01% 922
2014
Q3 		$100K Buy
5,140
+100
+2% +$2.83K ﹤0.01% 894
2014
Q2 		$183K Sell
5,040
-400
-7% -$13.6K ﹤0.01% 761
2014
Q1 		$211K Buy
5,440
+450
+9% +$16K ﹤0.01% 716
2013
Q4 		$135K Buy
4,990
+100
+2% +$2.94K ﹤0.01% 707
2013
Q3 		$175K Buy
+4,890
New +$178K ﹤0.01% 679

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RIGL Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Rigel Pharmaceuticals (RIGL) in Q4 2021, closing a stake of 4,960 shares — an estimated $178K sold.

DekaBank Deutsche Girozentrale first reported a position in RIGL in Q3 2013 and held it in 19 quarters. The position peaked at $250K in Q2 2019. 162 funds tracked by Wall St. Rank hold RIGL as of Q4 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Rigel Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 4,960 Rigel Pharmaceuticals shares in Q4 2021, an estimated $178K.
  • DekaBank Deutsche Girozentrale first reported a position in Rigel Pharmaceuticals in Q3 2013 and held it in 19 quarters.
  • DekaBank Deutsche Girozentrale's Rigel Pharmaceuticals position peaked at $250K in Q2 2019.
  • 162 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.